CHEK1 has been shown to be highly expressed in lung cancer cells, and importantly, miR-195 has been demonstrated to inhibit the progression and development of NSCLC by targeting CHEK1 [9]. The gene discussed is CHEK1; the disease is non-small cell lung carcinoma.